Skip to content

Observational Study of Baska Mask, a New Supraglottic Airway Device in Children

Observational Study of Baska Mask, a New Supraglottic Airway Device in Children

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01625078
Enrollment
20
Registered
2012-06-21
Start date
2012-03-31
Completion date
2013-06-30
Last updated
2014-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Baska Mask Efficacy and Safety in Children

Keywords

Baska Mask, Supraglottic airway device, Children, Pediatric

Brief summary

The investigators wish to accumulate initial data on the performance and safety of the Baska mask in paediatric patient population.

Interventions

Use of Baska mask as a supraglottic airway during general anesthesia

Sponsors

John Laffey
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
8 Years to 16 Years
Healthy volunteers
No

Inclusion criteria

* consent * BMI 15-35 * weight over 30kg or age 8-16 yrs * non-urgent surgery of planned duration up to 2 hrs

Exclusion criteria

* neck pathology * previous or anticipated problems with the upper GI or upper airway * increased risk of gastric aspiration * expected difficult airway

Design outcomes

Primary

MeasureTime frameDescription
Device insertion success ratewithin 30 minutes of induction of general anesthesia
device airway leak pressurewithin 10 minutes of successful device placementthe airway l;eak pressure is defined as the plateau airway pressure measured while the patient is apnoeic with the APL valve of the anaesthetic machine set to 35 cm H2O and the fresh gas flow set to 6 L/min

Secondary

MeasureTime frameDescription
airway stabilitywithin 30 minutes of device placementthe tidal volumes will be measured in different head positions and the leak fractions calculated.
ease of device placementwithin 30 minutes of induction of general anesthesiathe ease of device placement will be evaluated by Visual Analogue Scale
complications during the anestheticfrom the start of device insertion untill discharge from recovery, an expected average of 2 hourscomplications that may be related to the device use will be monitored including but not limited to desaturation episodes, laryngospasm, loss of airway, need to switch ot alternative device, blood staining on mask removal sore throat, dysphonia, dysphagia

Countries

Ireland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026